Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-04

Clinical Trial Update: A Study to Evaluate the Efficacy of a Purified Native Type 1 Collagen Extracellular Matrix With Polyhexamethylene Biguanide Antimicrobial (PCMP) and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot Ulcers [NA]

View source ↗

Summary

A clinical trial is evaluating a purified native type 1 collagen extracellular matrix with an antimicrobial (PCMP) added to standard of care versus standard of …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Purified native Type 1 Collagen Extracellular Matrix with Polyhexamethylene Biguanide Antimicrobial (PCMP) (Purified native Type 1 Collagen Extracellular Matrix with Polyhexamethylene Biguanide Antimicrobial)

Snippet

Sponsor: Organogenesis | Conditions: Diabetic Foot Ulcer | NA | Status: RECRUITING